Eniporide hydrochloride
目录号: PL07612 纯度: ≥98%
CAS No. :211813-86-4
商品编号 规格 价格 会员价 是否有货 数量
PL07612-5mg 5mg ¥1224.00 请登录
PL07612-10mg 10mg ¥2163.64 请登录
PL07612-25mg 25mg ¥4821.82 请登录
PL07612-50mg 50mg ¥8530.91 请登录
PL07612-100mg 100mg 询价 询价
PL07612-200mg 200mg 询价 询价
PL07612-10mM*1mLinDMSO 10mM*1mLinDMSO ¥1346.40 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Eniporide hydrochloride
中文别名
Eniporide hydrochloride
英文名称
Eniporide hydrochloride
英文别名
Eniporide hydrochloride
Cas No.
211813-86-4
分子式
C14H17ClN4O3S
分子量
356.83
包装储存
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
产品详情
Eniporide hydrochloride (EMD-96785 hydrochloride)是有效地 Na+/H+ 交换抑制剂。
生物活性
Eniporide hydrochloride (EMD-96785 hydrochloride) is a potent Na/H exchange inhibitor.
性状
Solid
IC50 & Target[1][2]
Sodium Channel
体外研究(In Vitro)
There is no significant effects of the Na/H exchange inhibitor eniporide on cardiac performance and high energy phosphate content in healthy pig hearts subjected to ischemia/reperfusion induced by crystalloid cardioplegic arrest. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
In stage 1, the administration of 100 mg and 150 mg eniporide results in smaller infarct sizes, especially in the angioplasty group. In contrast, in stage 2 there is no difference in the enzymatic infarct size between the three groups. Overall there is no effect of eniporide on clinical outcome (death, cardiogenic shock, heart failure, life-threatening arrhythmias). However, there is a significant reduction of the incidence of heart failure in patients reperfused late (>4 h). has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
参考文献
[1]. Klass O, et al. Effect of the Na+/H+ exchange inhibitor eniporide on cardiac performance and myocardial high energy phosphates in pigs subjected to cardioplegic arrest. Ann Thorac Surg. 2004 Feb;77(2):658-63.
[2]. Zeymer U, et al. The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol. 2001 Nov 15;38(6):1644-50.
溶解度数据
In Vitro: DMSO : 55 mg/mL (154.14 mM; Need ultrasonic)H2O : 4.17 mg/mL (11.69 mM; ultrasonic and warming and heat to 60°C)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2